F. Natanegara

发表

The current state of Bayesian methods in medical product development: survey results and recommendations from the DIA Bayesian Scientific Working Group

J. Seaman, B. Neuenschwander, D. Ohlssen, 2014, Pharmaceutical statistics.

Bayesian methods for the design and analysis of noninferiority trials

Guochen Song, Heinz Schmidli, Fanni Natanegara, 2016, Journal of biopharmaceutical statistics.

First-line treatment of patients with advanced or metastatic squamous non-small cell lung cancer: systematic review and network meta-analysis.

S. Able, F. Natanegara, A. Brnabic, 2018, Journal of thoracic disease.

Pharmacodynamics and pharmacokinetics of single doses of prasugrel 30 mg and clopidogrel 300 mg in healthy Chinese and white volunteers: an open-label trial.

R. Kelly, K. Winters, P. Kothare, 2010, Clinical therapeutics.

ORIGINAL RESEARCH—ED PHARMACOTHERAPY: Efficacy and Safety of Tadalafil Across Ethnic Groups and Various Risk Factors in Men with Erectile Dysfunction: Use of a Novel Noninferiority Study Design

C. Niederberger, F. Natanegara, A. Morgentaler, 2006 .

Study protocol: systematic review and meta-analysis of randomized controlled trials in first-line treatment of squamous non-small cell lung cancer

S. Able, F. Natanegara, L. Bowman, 2014, Systematic Reviews.

Tadalafil is efficacious and well tolerated in the treatment of erectile dysfunction (ED) in men over 65 years of age: results from Multiple Observations in Men with ED in National Tadalafil Study in the United States.

I. Sharlip, B. Shumaker, F. Natanegara, 2008, The journal of sexual medicine.

Efficacy and safety of tadalafil in men with erectile dysfunction with a high prevalence of comorbid conditions: results from MOMENTUS: multiple observations in men with erectile dysfunction in National Tadalafil Study in the US.

Edward D. Kim, I. Goldstein, W. Steers, 2007, The journal of sexual medicine.

Time from dosing to sexual intercourse attempts in men taking tadalafil in clinical trials

A. Burnett, I. Sharlip, I. Eardley, 2005, BJU international.

Tadalafil is efficacious in Black American and Hispanic men with erectile dysfunction: results from multiple observations in men with erectile dysfunction in national tadalafil study in the US (MOMENTUS)

R. Munarriz, F. Natanegara, P. Gomery, 2007, International Journal of Impotence Research.

Bayesian Sample Size Determination for a Clinical Trial with Correlated Continuous and Binary Outcomes

J. Seaman, J. Stamey, F. Natanegara, 2013, Journal of biopharmaceutical statistics.

Donanemab (LY3002813) dose‐escalation study in Alzheimer's disease

S. Shcherbinin, F. Natanegara, B. Willis, 2021, Alzheimer's & dementia.

875: High Prevalence of Significant Comorbid Conditions in Men with Erectile Dysfunction: Momentus Trial Demonstrates Efficacy and Safety of Tadalafil in this Group

Edward D. Kim, I. Goldstein, W. Steers, 2005 .

Response to treatment with tadalafil in men with erectile dysfunction who reported no successful intercourse attempts at baseline

R. Shinghal, F. Natanegara, R. Shabsigh, 2008, International Journal of Impotence Research.

Facilitated Prior Elicitation with the Wolfram CDF

Baoguang Han, Fanni Natanegara, David Kahle, 2016 .

Through the eyes of women: the partners' perspective on tadalafil.

F. Natanegara, G. Brock, S. Althof, 2006, Urology.

Pharmacokinetics and pharmacodynamics following maintenance doses of prasugrel and clopidogrel in Chinese carriers of CYP2C19 variants.

K. Winters, Lei-Bin Shen, R. Kelly, 2012, British journal of clinical pharmacology.

Phase II (NAVIGATE-AD study) Results of LY3202626 Effects on Patients with Mild Alzheimer’s Disease Dementia

S. Shcherbinin, F. Natanegara, B. Willis, 2021, Journal of Alzheimer's disease reports.

Daily patterns of sexual intercourse attempts by men with erectile dysfunction treated with tadalafil: influence of age and marital status

G. Broderick, F. Natanegara, S. Althof, 2009, International Journal of Impotence Research.

Using Digital Tools to Advance Alzheimer’s Drug Trials During a Pandemic: The EU/US CTAD Task Force

M. Carrillo, J. Kaye, P. Aisen, 2021, The Journal of Prevention of Alzheimer's Disease.

Statistical Opportunities to Accelerate Development for COVID-19 Therapeutics

Samiran Ghosh, Fanni Natanegara, Névine Zariffa, 2020, Statistics in Biopharmaceutical Research.

A single ascending dose study in healthy volunteers to assess the safety and PK of LY3372689, an inhibitor of O‐GlcNAcase (OGA) enzyme

C. Bundgaard, K. Biglan, F. Natanegara, 2020 .

Effects of a novel mGlu2/3 receptor agonist prodrug, LY2140023 monohydrate, on central monoamine turnover as determined in human and rat cerebrospinal fluid

R. Dean, K. Perry, D. McKinzie, 2012, Psychopharmacology.

Design and Execution of Sustainable Decentralized Clinical Trials

R. Beckman, F. Natanegara, Pritibha Singh, 2023, Clinical pharmacology and therapeutics.

Bayesian Sample Size Determination for a Clinical Trial with Correlated Continuous and Binary Outcomes

J. Seaman, J. Stamey, F. Natanegara, 2013, Journal of biopharmaceutical statistics.

Effects of a novel mGlu2/3 receptor agonist prodrug, LY2140023 monohydrate, on central monoamine turnover as determined in human and rat cerebrospinal fluid

R. Dean, K. Perry, D. McKinzie, 2011, Psychopharmacology.

Decision making in clinical trials: Interim analyses, innovative design, and biomarkers

G. Kerchner, M. Carrillo, K. Welsh-Bohmer, 2023, Alzheimer's & dementia.

Why are There not More Bayesian Clinical Trials? Ability to Interpret Bayesian and Conventional Statistics Among Medical Researchers

F. Harrell, F. Natanegara, N. Muehlemann, 2022, Therapeutic Innovation & Regulatory Science.

Why are not There More Bayesian Clinical Trials? Perceived Barriers and Educational Preferences Among Medical Researchers Involved in Drug Development

F. Harrell, F. Natanegara, R. Bray, 2022, Therapeutic Innovation & Regulatory Science.

MEDI1814 selectively reduces free Aβ42 in cerebrospinal fluid of non-clinical species and Alzheimer's disease patients.

N. Proctor, J. Dage, F. Natanegara, 2024, Alzheimer's & dementia : the journal of the Alzheimer's Association.